Emergency Room HPV Self-Sampling Study (ACT NOW)
ACT NOW
Feasibility and Effectiveness of HPV Self-Sampling for Cervical Cancer Screening Among Women Seeking Health Care At a Safety Net Hospital Emergency Room
1 other identifier
interventional
100
1 country
1
Brief Summary
The goal of this study is to develop and evaluate an evidence-based public health intervention using HPV self-sampling approach in an opportunistic setting to increase cervical cancer screening among screening non-attendees, particularly those uninsured or underinsured, who use emergency services to access medical care. The proposed pilot study will examine the feasibility and efficacy of HPV self-sampling among women at a safety net hospital emergency room. Participant recruitment and self-sample will take place in the waiting rooms in the ER. All women sitting in the waiting room will serve as the source population for the study and will be approached and invited to participate in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2023
CompletedFirst Submitted
Initial submission to the registry
December 12, 2023
CompletedFirst Posted
Study publicly available on registry
December 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 11, 2024
CompletedJanuary 15, 2025
June 1, 2024
5 months
December 12, 2023
January 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
HPV self-sampling completion
Participation rate for self-sample HPV testing (percent of eligible women who complete self-sampling).
1 day
Secondary Outcomes (2)
HPV self-sampling acceptability
1 day
Attendance for cervical cancer screening among HR-HPV positive women
6 months
Study Arms (1)
Intervention arm (single arm)
EXPERIMENTALIntervention arm to complete HPV self-sampling
Interventions
HPV self-sampling. Participants will be provided with education regarding cervical cancer prevention and Aptima kit and instructions for self-sampling. Patient navigators will assist participants with positive HPV test results to connect with healthcare providers for follow-up screening and care.
Eligibility Criteria
You may qualify if:
- Eligible participants are women ages 25 years to 65 years, with a cervix, presenting in the waiting areas at the Ben Taub General Hospital Emergency Department
You may not qualify if:
- Women under 25 years or older than 65 years of age,
- self-reported current pregnancy,
- self-reported history of cervical cancer,
- past hysterectomy,
- had Pap Smear within past 3 years or HPV/Pap co-test within past 5 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baylor College of Medicine
Houston, Texas, 77030, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 12, 2023
First Posted
December 21, 2023
Study Start
November 15, 2023
Primary Completion
April 11, 2024
Study Completion
October 11, 2024
Last Updated
January 15, 2025
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share